The Role of Autologous Stem Cell Transplantation in the Treatment of Diffuse Large B-Cell Lymphoma
Diffuse large B-cell non-Hodgkin’s lymphoma (DLBCL) accounting for approximately 30% of new lymphoma diagnoses in adult patients. Complete remissions (CRs) can be achieved in 45% to 55% of patients and cure in approximately 30–35% with anthracycline-containing combination chemotherapy. The ageadjust...
Saved in:
| Main Authors: | Marco Gunnellini, Rita Emili, Stefano Coaccioli, Anna Marina Liberati |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2012-01-01
|
| Series: | Advances in Hematology |
| Online Access: | http://dx.doi.org/10.1155/2012/195484 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
AUTOLOGOUS STEM CELL TRANSPLANTATION FOR AGGRESSIVE LYMPHOMAS
by: Giuseppe Visani, et al.
Published: (2012-11-01) -
OUTCOME OF PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA RELAPSING AFTER AUTOLOGOUS TRANSPLANT BEFORE AVAILABILITY OF CAR-T CELL TREATMENT
by: Ulrike Bacher, et al.
Published: (2023-04-01) -
Autologous stem cell transplantation for relapsed/refractory large B-cell lymphoma: a multicenter GETH-TC/GELTAMO study
by: Leyre Bento, et al.
Published: (2025-07-01) -
Impact of Autologous and Allogeneic Stem Cell Transplantation in Peripheral T-Cell Lymphomas
by: Peter Reimer
Published: (2010-01-01) -
SURVIVAL OUTCOMES OF AUTOLOGOUS STEM CELL TRANSPLANTATION IN LYMPHOMA PATIENTS
by: Elif Yıldız, et al.
Published: (2024-12-01)